Gain Therapeutics (GANX) EBITDA Margin (QoQ) (2020 - 2023)
Gain Therapeutics (GANX) EBITDA Margin (QoQ) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Gain Therapeutics | 87.26 Mn | 87.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -7.06 Mn |
| Jun 30, 2022 | 186,377.00 |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | -947,356.00 |
| Sep 30, 2021 | -1.24 Mn |
| Jun 30, 2021 | 4.22 Mn |
| Mar 31, 2021 | -2.91 Mn |
| Dec 31, 2020 | -544,595.00 |
| Sep 30, 2020 | -387,750.00 |
| Jun 30, 2020 | -67,841.00 |